Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer

NCT00867321 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: sorafenib tosylate

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]